Hainan Poly Pharm's significant ROE, steady earnings growth,...

Hainan Poly Pharm's significant ROE, steady earnings growth, and efficient reinvestment of retained earnings lead to a standout performance. Experts believe the company's growth rate will remain consistent. Stock rose by 23% within a month, indicating a positive market response.